Unknown

Dataset Information

0

Probing the effects of residues located outside the agonist binding site on drug-receptor selectivity in the nicotinic receptor.


ABSTRACT: The nicotinic acetylcholine receptors (nAChRs) are a family of closely related but pharmacologically distinct neurotransmitter-gated ion channels. They are therapeutic targets for a wide range of neurological disorders, and a key issue in drug development is selective targeting among the more than 20 subtypes of nAChRs that are known. The present work evaluates a proposed hydrogen bonding interaction involving a residue known as the "loop B glycine" that distinguishes receptors that are highly responsive to ACh and nicotine from those that are much less so. We have performed structure-function studies on the loop B site, including unnatural amino acid mutagenesis, in three different nAChR subtypes and found that the correlation between agonist potency and this residue is strong. Low potency receptor subtypes have a glycine at this key site, and mutation to a residue with a side chain converts a low potency receptor to a high potency receptor. Innately high potency receptors have a lysine at the loop B site and show a decrease in potency for the reverse mutation (i.e., introducing a glycine). This residue lies outside of the agonist binding site, and studies of other residues at the agonist binding site show that the details of how changes at the loop B glycine site impact agonist potency vary for differing receptor subtypes. This suggests a model in which the loop B residue influences the global shape of the agonist binding site rather than modulating any specific interaction.

SUBMITTER: Puskar NL 

PROVIDER: S-EPMC3356501 | biostudies-literature | 2012 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Probing the effects of residues located outside the agonist binding site on drug-receptor selectivity in the nicotinic receptor.

Puskar Nyssa L NL   Lester Henry A HA   Dougherty Dennis A DA  

ACS chemical biology 20120214 5


The nicotinic acetylcholine receptors (nAChRs) are a family of closely related but pharmacologically distinct neurotransmitter-gated ion channels. They are therapeutic targets for a wide range of neurological disorders, and a key issue in drug development is selective targeting among the more than 20 subtypes of nAChRs that are known. The present work evaluates a proposed hydrogen bonding interaction involving a residue known as the "loop B glycine" that distinguishes receptors that are highly r  ...[more]

Similar Datasets

| S-EPMC2700159 | biostudies-literature
| S-EPMC6842111 | biostudies-literature
| S-EPMC8022356 | biostudies-literature
| S-EPMC2234212 | biostudies-literature
| S-EPMC2654246 | biostudies-literature
| S-EPMC6491904 | biostudies-literature
| S-EPMC3024770 | biostudies-literature
| S-EPMC4398594 | biostudies-literature
| S-EPMC3341175 | biostudies-literature
| S-EPMC3162463 | biostudies-literature